• <tr id='MGuePI'><strong id='MGuePI'></strong><small id='MGuePI'></small><button id='MGuePI'></button><li id='MGuePI'><noscript id='MGuePI'><big id='MGuePI'></big><dt id='MGuePI'></dt></noscript></li></tr><ol id='MGuePI'><option id='MGuePI'><table id='MGuePI'><blockquote id='MGuePI'><tbody id='MGuePI'></tbody></blockquote></table></option></ol><u id='MGuePI'></u><kbd id='MGuePI'><kbd id='MGuePI'></kbd></kbd>

    <code id='MGuePI'><strong id='MGuePI'></strong></code>

    <fieldset id='MGuePI'></fieldset>
          <span id='MGuePI'></span>

              <ins id='MGuePI'></ins>
              <acronym id='MGuePI'><em id='MGuePI'></em><td id='MGuePI'><div id='MGuePI'></div></td></acronym><address id='MGuePI'><big id='MGuePI'><big id='MGuePI'></big><legend id='MGuePI'></legend></big></address>

              <i id='MGuePI'><div id='MGuePI'><ins id='MGuePI'></ins></div></i>
              <i id='MGuePI'></i>
            1. <dl id='MGuePI'></dl>
              1. <blockquote id='MGuePI'><q id='MGuePI'><noscript id='MGuePI'></noscript><dt id='MGuePI'></dt></q></blockquote><noframes id='MGuePI'><i id='MGuePI'></i>
                  Profile Core value Main business Legitimacy Social Responsibility
                    Patents Research Direction Technology Strength
                  API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
                  Production management QC Quality System branch factory




                  Products Center
                Paclitaxel (Semi-synthetic)
                Paclitaxel (Natural)
                Docetaxel Anhydrous
                Docetaxel Trihydrate
                Irinotecan HCl Trihydrate 99.5%
                Etoposide USP31
                Palonosetron Hydrochloride
                  N-1 stage of Paclitaxel and Docetaxel
                  Main Intermediates
                10-Deacetylbaccatin III
                Baccatin III
                  Side chain for Paclixel semi-Synthetic
                (4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
                  Side chain of Docetaxel
                (4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
                  Side chain for Paclitaxel and Docetaxel
                Ethyl (2R,3S)-3-Phenylisoserine Ester
                Your location >>Home>>About us>>profile
                Shanghai Jinhe Bio-Pharmaceutical Co., Ltd. (Abrr. "Jinhe") , founded in March 2002, is a pharmaceutical enterprise dedicated to R&D, manufacturing and marketing anti-cancer APIs and their intermediates. Based on the R&D achievement of Fudan University, we began to undertake the international business of processing Paclitaxel API. After years of effort, we successfully developed Paclitaxel, Docetaxel, Irinotecan, Etoposide etc, from natural extracting anti-cancer products into material source anti-cancer APIs. In recent years, we developed new APIs, such as Cabazitaxel, Palonosetron hydrochloride etc. In 2012, we cooperated with Shanghai Zhongxi Sunve Pharmaceutical Co.,Ltd, (Abrr. "Sunve") became a member of Shanghai Pharmaceuticals Holding Co.,Ltd. (Abrr. "SPH"). Since then, we targeted ourselves as the production base of SPH on oncology products. In 2015, we and Shanghai Huayu Chinese Herbs Co., Ltd. (Abrr. "Huayu") both subsidiaries of SPH, reorganized Dali Zhonggu Yew Biological Co., Ltd. (Abrr. "Zhonggu Biological") by way of investment in cash. This move indicates that SPH will further integrate its oncology drug industry chain and build its advantage in APIs. In January 2017, we achieved GMP certificate on Bulk Drug (Paclitaxel, Docetaxel). We are always committed to be a competitive and responsible company in global pharmaceutical industry.

                CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
                HOME About us Products R & D Production and QA Contact us CHINESE